Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Cilengitide and Sunitinib Malate in Treating Patients With Advanced Solid Tumors or Glioblastoma Multiforme

This study has been terminated.
Information provided by (Responsible Party):
National Cancer Institute (NCI) Identifier:
First received: January 12, 2010
Last updated: April 27, 2015
Last verified: April 2015
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: April 2015
  Primary Completion Date: September 2012 (Final data collection date for primary outcome measure)